This is a preview of subscription content, log in via an institution to check access.
Notes
human epidermal growth factor receptor 2
Reference
Franchi M, et al. Effectiveness and Healthcare Cost of Adding Trastuzumab to Standard Chemotherapy for First-Line Treatment of Metastatic Gastric Cancer: A Population-Based Cohort Study. Cancers : 25 Jun 2020. Available from: URL: https://doi.org/10.3390/cancers12061691
Rights and permissions
About this article
Cite this article
Trastuzumab cost effective in HER2-positive metastatic gastric cancer. PharmacoEcon Outcomes News 858, 31 (2020). https://doi.org/10.1007/s40274-020-7004-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7004-1